“Omalizumab Improves Angioedema-Related Quality of Life Impariment in Patients With Chronic Idiopathic Chronic Spontaneous Urticaria: Results from the X-Act Study”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S53. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/299.